|
PDK3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.89549999999917E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.030600E-04 |
| Normal-vs-Stage2 |
2.411100E-04 |
| Normal-vs-Stage3 |
1.231770E-04 |
| Normal-vs-Stage4 |
2.703100E-03 |
| Stage1-vs-Stage2 |
2.809400E-01 |
| Stage1-vs-Stage3 |
2.760400E-01 |
| Stage1-vs-Stage4 |
6.257600E-01 |
| Stage2-vs-Stage3 |
8.169200E-01 |
| Stage2-vs-Stage4 |
5.868400E-01 |
| Stage3-vs-Stage4 |
7.073200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.629700E-04 |
| Normal-vs-AfricanAmerican |
1.79709999992284E-07 |
| Normal-vs-Asian |
5.851800E-01 |
| Caucasian-vs-AfricanAmerican |
6.579900E-03 |
| Caucasian-vs-Asian |
4.503600E-01 |
| AfricanAmerican-vs-Asian |
4.337600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.027700E-04 |
| Normal-vs-Female |
6.03869999999951E-05 |
| Male-vs-Female |
6.235800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.813100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.237700E-04 |
| Normal-vs-Age(61-80Yrs) |
7.429800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.161800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.125000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.621970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.552200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.301000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.653400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.217000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.840000E-01 |
| Normal-vs-Grade 2 |
1.79188999999136E-05 |
| Normal-vs-Grade 3 |
3.960600E-04 |
| Normal-vs-Grade 4 |
3.545800E-02 |
| Grade 1-vs-Grade 2 |
3.378400E-01 |
| Grade 1-vs-Grade 3 |
5.256200E-01 |
| Grade 1-vs-Grade 4 |
8.260800E-01 |
| Grade 2-vs-Grade 3 |
4.146200E-01 |
| Grade 2-vs-Grade 4 |
2.772000E-01 |
| Grade 3-vs-Grade 4 |
5.492600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.961200E-04 |
| Normal-vs-ccB subtype |
8.900300E-03 |
| ccA subtype-vs-ccB subtype |
5.804600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.030640E-04 |
| Normal-vs-N1 |
4.424000E-02 |
| N0-vs-N1 |
9.173000E-01 |
|
|
